Bristol Myers Squibb (BMY) Raw Materials (2010 - 2013)

Bristol Myers Squibb (BMY) has 4 years of Raw Materials data on file, last reported at $338.0 million in Q1 2013.

• Raw Materials for Q1 2013 came in at $338.0 million, up 40.25% year-over-year; the trailing twelve-month figure through Mar 2013 was $338.0 million (up 40.25% YoY), and the FY2012 annual result was $271.0 million, up 4.23% from the prior year.
• Raw Materials advanced to $338.0 million in Q1 2013 per BMY's latest filing, from $271.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $357.0 million in Q2 2011 and troughed at $199.0 million in Q4 2010.
• A 4-year average of $264.8 million and a median of $261.5 million in 2011 frame the typical range for Raw Materials.
• On a YoY basis, Raw Materials climbed as much as 44.39% in 2012 and fell as far as 26.33% in 2012.
• A 4-year view of Raw Materials shows it stood at $199.0 million in 2010, then soared by 30.65% to $260.0 million in 2011, then advanced by 4.23% to $271.0 million in 2012, then gained by 24.72% to $338.0 million in 2013.
• Business Quant data shows BMY's Raw Materials at $338.0 million in Q1 2013, $271.0 million in Q4 2012, and $296.0 million in Q3 2012.